Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants
Paula Berman, Janka Höfer, Herschel Mehlman, Efrat Almekias-Siegl, Olga Khersonsky, Younghui Dong, Uwe Heinig, Liron Sulimani, Let Kho Hao, Shahar Cohen, Yoav Peleg, Sagit Meir, Ilana Rogachev, David Meiri, Sarel J. Fleishman, Asaph Aharoni
Science Advances April 1, 2026 DOI: 10.1126/sciadv.aeb3034 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Citations | 1 |
| Key findings | A versatile platform was established for concurrent biosynthesis and diversification of psychoactive indolethylamines in plants, enabling substantially more efficient production and creation of halogenated analogs with prospective therapeutic potential. |
Abstract
-dimethyltryptamine (DMT) biosynthetic pathway in hallucinogenic plant species traditionally used in shamanic rituals for spiritual healing. Leveraging the similarities in their chemical structures, we reconstructed in one plant assay the full biosynthetic pathways of five renowned natural psychedelics; psilocin and psilocybin found in mushrooms, DMT from plants, and bufotenin and 5-methoxy-DMT secreted by the Sonoran Desert toad. We further engineered halogenated analogs of these molecules, which do not naturally occur in plants and exhibit prospective therapeutic potential for psychiatric conditions. Blending catalytic functions across the tree of life, coupled with metabolic engineering guided by rational protein design of mutant enzymes, enabled substantially more efficient in planta production of the indolethylamine components. This work establishes a versatile platform for concurrent biosynthesis and diversification of psychoactive indolethylamines, paving the way for their production in plants.
Citations in the library
Cited by 2
- Quantitative multi-tissue profiling of tryptamines, phenethylamines, and β-carbolines across 53 species of Australian Acacia Biochemical Systematics and Ecology October 7, 2026
- Reconstituting a two-step pathway for N,N-dimethyltryptamine (DMT) biosynthesis in bacteria Metabolic Engineering Communications July 1, 2026
Cites 27
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Journal of Pharmacology and Experimental Therapeutics June 18, 2003
- The neural basis of psychedelic action. Nature Neuroscience October 24, 2022
- Enzymatic Synthesis of Psilocybin Angewandte Chemie International Edition August 1, 2017
- Hallucinogens and dissociative agents naturally growing in the United States. Pharmacology & Therapeutics May 1, 2004
- Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Current Drug Metabolism October 1, 2010
and 22 more in the library